Remiges Ventures is a cross-border life sciences venture capital firm that focuses on early-stage drug discovery and therapeutic development. The firm actively creates and incubates new companies utilizing innovative intellectual property sourced from Japanese academic institutions while also leading or participating in global Series A syndicates.
About Remiges Ventures
Remiges Ventures positions itself as a cross-border life sciences investor with a Japan-United States bridge as a recurring theme in its strategy, backing therapeutics, medical device, and digital health companies that benefit from access to Asian strategic partners and capital. Public detail on stage and check size is limited from the inputs provided, but firms in this niche typically deploy Series A and Series B checks ranging from roughly two to ten million dollars per round and reserve heavily for follow-on. The natural fit is a healthcare company with a credible scientific or clinical thesis that has either an Asian commercialization opportunity or an interest in tapping Japanese pharma partnerships and licensing. AI-native founders should know that Remiges has historically leaned more toward biology and device assets than pure software, so a digital-only thesis without a regulated product or therapeutic angle is unlikely to resonate. Founders should approach with a clean data package, a clear regulatory pathway, and an explicit statement of why a Japan-United States investor adds something a domestic generalist would not. The best entry path is a warm referral from a portfolio CEO, a banker covering crossover healthcare deals, or a strategic at a Japanese pharma. Without that, a concise outreach via the firm’s website with the executive summary attached is the realistic alternative. Expect diligence that includes scientific advisors, regulatory counsel, and probable conversations with potential Asian partners. This is a partner-track investor for the right asset, not a quick-close generalist.
Founder reviews
Other portfolio companies
Companies in Remiges Ventures's portfolio not currently in our directory.
Team
Pitch / review this investor
Have you raised from Remiges Ventures? Founders only — share your honest experience (anonymous OK, moderated before publishing).